LEIDEN, The Netherlands, May 25, 2023
/PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management
will attend the following investor conferences in the month of
June:
- Jefferies Healthcare Conference, New York, U.S., June 7
- 9
Pharming's CEO, Sijmen de Vries, will present on Thursday, June 8 at 10:30
EST / 16:30 CEST. A live
webcast and replay of the presentation will be available in the
"Upcoming Events" and "News" sections of Pharming's website.
- Stifel European Healthcare Summit, Bordeaux, France, June
28 - 30
- IEX Beleggers dag (IEX Shareholder's day), Bussum,
the Netherlands, June 30
Pharming's CEO, Sijmen de Vries,
will present on Friday, June 30 at
11:30 CEST / 05:30 EST
Pharming's management will be available for one-to-one investor
meetings during the Jefferies and Stifel conferences.
For more information about these conferences, or to schedule a
one-to-one with Pharming's management team, please contact your
Jefferies or Stifel representative, or send an email to Pharming's
Investor Relations team to investor@pharming.com.
About Pharming Group N.V.
Pharming Group N.V.
(Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global
biopharmaceutical company dedicated to transforming the lives of
patients with rare, debilitating, and life-threatening diseases.
Pharming is commercializing and developing an innovative portfolio
of protein replacement therapies and precision medicines, including
small molecules, biologics, and gene therapies that are in early to
late-stage development. Pharming is headquartered in Leiden,
Netherlands, and has employees
around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and find us on
LinkedIn.
For further public information, contact:
Pharming Group, Leiden, The
Netherlands
Michael Levitan, VP Investor Relations & Corporate
Communications
T: +1 (908) 705 1696
Heather Robertson, Investor
Relations & Corporate Communications Manager
E: investor@pharming.com
FTI Consulting, London,
UK
Victoria Foster
Mitchell/Alex Shaw/Amy
Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon
Melens T: +31 6 53 81 64 27 E: pharming@lifespring.nl
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pharming-group-to-attend-the-following-investor-conferences-in-june-301833984.html
SOURCE Pharming Group N.V.